Method of reducing the risk of bone fracture
AssigneeEli Lilly and Company
InventorsGregory A. Gaich, Willard H. Dere, Janet M. Hock
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for increasing the toughness and/or stiffness of bone and/or reducing the likelihood and/or severity of bone fracture by administering a parathyroid hormone. The method can be employed to increase toughness or stiffness of bone at a site of a potential or actual trauma, such as the hip or spine of a person at risk of or suffering from osteoporosis. The method of the invention can reduce the incidence of vertebral fracture, reduce the incidence of multiple vertebral fractures, reduce the severity of vertebral fractur and/or reduce the incidence of non-vertebral fracture.
Claims4
A method for the treatment of a woman with osteoporosis and at risk for bone fracture comprising administering to said woman human parathyroid hormone (1-34) in a daily dose of 20 μg, without concurrent administration of an antiresorptive agent other than vitamin D or calcium, said treatment reducing the risk of vertebral and nonvertebral bone fracture.
A method for the treatment of a man with osteoporosis and at risk for bone fracture comprising administering to said man human parathyroid hormone (1-34) in a daily dose of 20 μg, without concurrent administration of an antiresorptive agent other than vitamin D or calcium, said treatment reducing the risk of vertebral and non-vertebral bone fracture.
Dependencies are inferred from the claim text.